| 000 | 01527 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513095222.0 | ||
| 264 | 0 | _c19960919 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/0005-2736(96)00075-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEberhardson, M | |
| 245 | 0 | 0 |
_aThe role of plasma membrane K+ and Ca2+ permeabilities for glucose induction of slow Ca2+ oscillations in pancreatic beta-cells. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cAug 1996 |
||
| 300 |
_a67-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channel Agonists _xpharmacology |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xphysiology |
| 650 | 0 | 4 |
_aGlucose _xpharmacology |
| 650 | 0 | 4 |
_aIslets of Langerhans _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Obese |
| 650 | 0 | 4 | _aPeriodicity |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aTetraethylammonium |
| 650 | 0 | 4 |
_aTetraethylammonium Compounds _xpharmacology |
| 700 | 1 | _aTengholm, A | |
| 700 | 1 | _aGrapengiesser, E | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1283 _gno. 1 _gp. 67-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0005-2736(96)00075-2 _zAvailable from publisher's website |
| 999 |
_c8761940 _d8761940 |
||